What is the differential diagnosis of generalized jaundice?

Differential Diagnosis of Generalized Jaundice

The differential diagnosis of jaundice is best organized by first determining whether hyperbilirubinemia is unconjugated (prehepatic) or conjugated (hepatic/posthepatic), then systematically categorizing causes into prehepatic, intrahepatic, and posthepatic etiologies. 1

Initial Classification Framework

Laboratory fractionation of bilirubin into unconjugated versus conjugated forms is the essential first step that fundamentally guides the entire differential diagnosis. 1 Urine bilirubin testing can rapidly confirm conjugated hyperbilirubinemia at the bedside. 2

Alkaline Phosphatase and Transaminase Patterns Guide Categorization:

• Elevated alkaline phosphatase suggests cholestatic (posthepatic) causes 1, 3
• Elevated transaminases (AST/ALT) suggest hepatocellular (intrahepatic) causes 1, 3
• Mixed patterns require imaging correlation to differentiate intrahepatic from extrahepatic obstruction 1

Prehepatic Causes (Unconjugated Hyperbilirubinemia)

Hemolytic Disorders:

• Hemolysis accounts for 2.5% of jaundice cases 4
• Coombs-negative hemolytic anemia occurs in 10-25% of chronic liver disease patients with jaundice 4
• Hematoma resorption can produce unconjugated hyperbilirubinemia 2

Inherited Bilirubin Metabolism Disorders:

• Gilbert syndrome represents 5.6% of jaundice cases 4
• Crigler-Najjar syndrome creates constitutional unconjugated hyperbilirubinemia 4
• Dubin-Johnson and Rotor syndromes cause conjugated hyperbilirubinemia 5

Intrahepatic Causes (Mixed or Conjugated Hyperbilirubinemia)

Most Common Etiologies in Order of Frequency:

Sepsis/shock is the single most common cause in U.S. studies, accounting for 22-27% of severe jaundice cases, creating both hemolysis and hepatic dysfunction with mixed unconjugated and conjugated hyperbilirubinemia. 4, 1 Look for fever, rigors, and right-upper-quadrant pain as clinical clues. 4

Decompensation of pre-existing cirrhosis is the second most common cause at 20.5%, representing the primary mechanism in established chronic liver disease patients. 4

Alcoholic liver disease accounts for 16% of cases, with alcoholic hepatitis commonly presenting as the first manifestation of decompensated disease. 4

Drug-induced liver injury represents 0.5-7% of cases and constitutes one of the four most common causes in the United States; review medication exposure within the prior six weeks. 4

Cirrhosis and Portal Hypertension:

• Cirrhosis of any etiology can present with cholestatic jaundice, and when accompanied by hepatomegaly and splenomegaly, strongly favors an intrahepatic cause 4
• Congestive hepatopathy from right-sided heart failure causes hepatic congestion with cholestasis and can progress to cardiac cirrhosis 4

Vascular Disorders:

• Budd-Chiari syndrome (hepatic vein thrombosis) produces the triad of hepatomegaly, splenomegaly, and cholestatic jaundice 4
• Hepatic veno-occlusive disease yields similar findings 4

Infiltrative Disorders:

Malignant infiltration:

• Hematologic malignancies (lymphoma, leukemia, multiple myeloma) diffusely infiltrate the liver, producing cholestasis with hepatosplenomegaly 4
• Metastatic carcinoma creates an infiltrative intrahepatic cholestatic pattern 4
• Paraneoplastic syndromes (Hodgkin disease, renal cell carcinoma) can cause cholestasis without direct hepatic infiltration 4

Benign infiltration:

• Hepatic sarcoidosis leads to granulomatous infiltration with cholestasis and hepatosplenomegaly 4
• Systemic amyloidosis may involve both liver and spleen 4

Viral and Autoimmune Hepatitis:

• Viral hepatitis accounts for only 0.2% of severe jaundice cases but remains important 4
• Autoimmune hepatitis represents 0.2% of severe jaundice cases 4

Advanced Primary Biliary Disorders:

• Advanced primary biliary cholangitis (PBC) frequently develops portal hypertension with splenomegaly; test for antimitochondrial antibodies (AMA) when suspected 4
• Primary sclerosing cholangitis (PSC) commonly progresses to cirrhosis, with hepatomegaly and splenomegaly as the most frequent findings at diagnosis 4
• IgG4-associated cholangitis can mimic PSC; measure serum IgG4 levels when diagnosis is uncertain 4

Posthepatic Causes (Conjugated Hyperbilirubinemia with Biliary Obstruction)

Mechanical Obstruction:

Choledocholithiasis (common bile duct stones) represents 13-14% of jaundice cases, with multiple small gallstones (<5 mm) creating 4-fold increased risk for CBD migration. 4 This produces dark urine and pale or clay-colored stools as conjugated bilirubin cannot be excreted into the intestines. 1

Malignancy accounts for 6.2% of U.S. jaundice cases but represents the most common etiology of severe jaundice in European populations. 4 The differential in chronic pancreatitis includes pancreatic adenocarcinoma and Mirrizi's syndrome. 3

Other obstructive causes include biliary strictures and pancreatitis. 1

Diagnostic Algorithm

Step 1: Laboratory Testing

• Total and fractionated bilirubin (conjugated vs. unconjugated) 1, 3
• Complete blood count 3
• Liver enzymes: AST, ALT, alkaline phosphatase, GGT 3
• Synthetic function tests 3

Step 2: Immediate Imaging

Abdominal ultrasonography should be performed immediately to rule out dilated bile ducts, detect mass lesions, and assess liver texture and spleen size. 4 Ultrasound has 65-95% sensitivity for detecting cirrhosis and 32-100% sensitivity for biliary obstruction. 4

The concurrent presence of hepatomegaly and splenomegaly on ultrasound strongly favors an intrahepatic cause rather than simple extrahepatic biliary obstruction. 4

Step 3: Advanced Imaging When Needed

If ultrasound does not reveal ductal dilatation but clinical suspicion persists, magnetic resonance cholangiopancreatography (MRCP) should be considered. 4 Further imaging with CT or ERCP may be necessary based on ultrasound findings. 3

Step 4: Histologic Evaluation

Liver biopsy is indicated when non-invasive studies are inconclusive; a specimen should contain at least ten portal tracts for adequate assessment. 4 Biopsy findings are categorized into: (1) bile-duct-related disorders, (2) non-bile-duct hepatocellular disorders, and (3) primary hepatocellular cholestasis. 4

Critical Pitfalls to Avoid

Never delay ultrasonography while awaiting extensive laboratory results, as this can postpone critical diagnosis. 4

In sepsis patients, always fractionate bilirubin because both hemolysis and hepatic dysfunction create mixed patterns that require laboratory differentiation. 1

Differentiating intrahepatic from extrahepatic cholestasis is the first essential step because it determines the subsequent differential diagnosis and management pathway. 4